HomeCTXR • NASDAQ
add
Citius Pharmaceuticals Inc
Previous close
$3.71
Day range
$3.55 - $3.82
Year range
$2.44 - $26.75
Market cap
31.19M USD
Avg Volume
441.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.05M | 9.14% |
Net income | -10.79M | -8.51% |
Net profit margin | — | — |
Earnings per share | -5.80 | -231.43% |
EBITDA | -11.05M | -9.15% |
Effective tax rate | -1.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.25M | -87.72% |
Total assets | 116.65M | 12.59% |
Total liabilities | 42.55M | 249.35% |
Total equity | 74.10M | — |
Shares outstanding | 7.73M | — |
Price to book | 0.38 | — |
Return on assets | -25.85% | — |
Return on capital | -34.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.79M | -8.51% |
Cash from operations | -5.91M | 13.05% |
Cash from investing | -5.00M | — |
Cash from financing | -3.75M | -545,260.12% |
Net change in cash | -14.66M | -115.55% |
Free cash flow | 21.57M | 758.33% |
About
Founded
2007
Headquarters
Website
Employees
23
